(IN BRIEF) At the Technical University of Munich, doctoral researcher Yixiao Zhang is pioneering the development of nanoscale catalysts that transform pollutants in wastewater into valuable materials such as urea, the world’s most widely used solid fertilizer. Her research seeks … Read the full press release
Posted in Education, Energy, Gas & Oil, Environment, Germany, Management, Science, Technology
Tagged Aliaksandr Bandarenka, Bosch-Meiser process, climate-friendly innovation, copper catalysts, Deutsches Museum, e-conversion, Electrochemistry, Escape from Carbonia, Green Chemistry, Kunstareal München, nanotechnology, nitrogen utilization, renewable energy, resource recovery, sustainability, Technical University of Munich, TUM Campus Straubing, TUM School of Natural Sciences, TUM Scientist Yixiao Zhang Combines Green Chemistry and Public Engagement in Award-Winning Sustainability Research, Turning Waste into Value: TUM Researcher Yixiao Zhang Develops Catalysts for Sustainable Urea Production, urea synthesis, wastewater treatment, Wissenschaft im Dialog, Yixiao Zhang
(IN BRIEF) Boehringer Ingelheim has licensed a pre-clinical small molecule program from Kyowa Kirin to develop a potential first-in-class therapy for autoimmune diseases, a major global health challenge affecting around 10% of the population. The deal grants Boehringer exclusive worldwide … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged autoimmune diseases, biotechnology, Boehringer Ingelheim, Boehringer Ingelheim Secures Exclusive Global Rights to Develop New Autoimmune Treatment from Kyowa Kirin, Boehringer Ingelheim Strengthens Autoimmune Disease Pipeline with Licensing Agreement from Kyowa Kirin, Carine Boustany, chronic inflammation, drug development, global health, immunology, inflammatory diseases, Kyowa Kirin, licensing agreement, pharmaceutical innovation, pre-clinical program, respiratory diseases, small molecule therapy, Takeyoshi Yamashita
(IN BRIEF) Causeway Therapeutics, a University of Glasgow spin-out, has announced strong Phase 2 results for its novel microRNA therapy, TenoMiR®, used to treat tennis elbow. The study, involving 123 patients across the UK and USA, showed significant improvements in … Read the full press release
Posted in Education, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biotechnology, Causeway Therapeutics, Causeway Therapeutics Advances TenoMiR® Development Following Strong Phase 2 Results, clinical research, Declan Doogan, Derek Gilchrist, Glasgow City Council, Glasgow Riverside Innovation District, Iain McInnes, lateral epicondylitis, microRNA therapy, miR29a, Neal Millar, orthopaedic innovation, phase 2 trial, Phase 3 development, Promising Clinical Data Propel Glasgow Biotech Causeway Therapeutics Toward Full Development of TenoMiR®, Scott Rodeo, Scottish Enterprise, tendinopathy, tendon regeneration, tennis elbow, TenoMiR, University of Glasgow
Pertussis cases surge: Over 60,000 reported in Europe; infants most at risk. Maternal vaccination expands: Finland, Norway, and UK updated pregnancy vaccine strategies. BioNet advances: Submitted recombinant pertussis vaccine to EMA; secured EU-GMP approval. Nasal vaccine progresses: ILiAD’s BPZE1 granted … Read the full press release
Posted in Denmark, European Union, Finland, France, Germany, Healthcare, Ireland, News, Norway, Pharma & Biotech, Science, United Kingdom
Tagged acellular pertussis vaccine, Adacel, antibody avidity, antigen dose, ASEAN, Bio Farma, BioNet, biotechnology, booster dose, Boostrix-IPV, BPZE1, certification, Chulalongkorn University, clinical trial, compliance, Dario Cresci, dTap, ECDC, EMA, EU-GMP, EU-GMP certification, EU/EEA, Europe Confronts Pertussis Resurgence as Infant Cases Rise Amid Falling Immunity and Vaccination Gaps, Europe Faces Pertussis Resurgence Amid Waning Immunity and Falling Maternal Vaccination Rates, European Medicines Agency, European Union, European Union Good Manufacturing Practice, Europe’s Pertussis Vaccine Market Opens to New Entrants as Demand Rises, From EU-GMP Certification to ASEAN Partnerships BioNet Broadens Its Global Vaccine Strategy, GMP production facilities, GSK, Hanna Nohynek, health policy, HPRA, human challenge trial, hVIVO, ILiAD Biotechnologies, immunization strategy, infant protection, Innovation Passport, Institut Pasteur, intranasal vaccine, Ireland Health Products Regulatory Authority, Lancet Infectious Diseases, maternal vaccination, MHRA, mucosal immunity, outbreak, pandemic recovery, Pertagen®, pertussis, pertussis vaccine, Pertussis Vaccine Manufacturing, pharmaceutical quality, Phase 3, Philippe Guillot-Chêne, pregnancy immunization, public health, recombinant pertussis vaccine, recombinant pertussis vaccines, regulatory approval, Sanofi, Tdap, TdaP combination vaccine, V, vaccine, vaccine blunting, vaccine development, Vaccine Hesitancy, vaccine pipeline, vaccine rollout, vaccine shortage, vaccine supply, vaccine uptake, VacPertagen, whooping cough
(IN BRIEF) Fresenius Medical Care will present multiple studies at ASN Kidney Week 2025, highlighting how hemodiafiltration (HDF) enhances clinical outcomes and how artificial intelligence is transforming kidney care. One of the featured oral presentations links HDF to a reduced … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Marketing, Pharma & Biotech, Science, Technology
Tagged AI Chatbot, AI in healthcare, ASN Kidney Week 2025, cardiovascular outcomes, clinical research, dialysis, digital innovation, Frank Maddux, Fresenius Medical Care, Fresenius Medical Care Highlights Real-World Benefits of Hemodiafiltration and AI Innovation at ASN Kidney Week in Houston, HDF, hemodiafiltration, HOUSTON, kidney disease, kidney therapy, nephrology, online high-volume HDF, patient care, precision medicine, Renal Research Institute
(IN BRIEF) Brenntag has entered a new partnership with Givaudan to distribute active cosmetic ingredients across Thailand’s fast-growing beauty and personal care markets. The agreement expands Brenntag’s specialty portfolio, supported by its Thailand Application and Innovation Centre, which provides formulation … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Germany, News, Science, Technology
Tagged active ingredients, Application and Innovation Centre, Asia Pacific, Beauty Industry, biocosmetics, Bonwook Koo, Brenntag, Brenntag Expands Thai Beauty Portfolio Through New Distribution Partnership with Givaudan, cosmetics, formulation support, fragrance and beauty, Givaudan, Givaudan Active Beauty, haircare, ingredient distribution, INNOVATION, personal care, skincare, sustainability, THAILAND, wellness, Wissanee Ruangsorn
BioNet earns EU-GMP certification for its acellular pertussis vaccine, confirming compliance with EU manufacturing and quality standards. Inspection by Ireland’s HPRA supports EMA review of BioNet’s recombinant vaccine candidate VacPertagen. Partnerships expanding: MoU with Indonesia’s Bio Farma to accelerate TdaP … Read the full press release
Posted in European Union, France, Healthcare, Ireland, Pharma & Biotech, Science
Tagged acellular pertussis vaccine, BioNet, BioNet’s EU-GMP Certification Marks Strategic Step Toward EMA Review and Expands Global Vaccine Reach, BioNet’s Manufacturing Accreditation Aligns with Growing International Efforts to Reinforce Pertussis Vaccine Supply, biotechnology, certification, compliance, Dario Cresci, EMA, EU-GMP certification, European Medicines Agency, European Union, European Union Good Manufacturing Practice, From EU-GMP Certification to ASEAN Partnerships BioNet Broadens Its Global Vaccine Strategy, GMP production facilities, HPRA, Ireland Health Products Regulatory Authority, Pertagen®, pertussis, pertussis vaccine, Pertussis Vaccine Manufacturing, pharmaceutical quality, Philippe Guillot-Chêne, recombinant pertussis vaccines, Regulatory Milestone and Research Progress Signal BioNet’s Expanding Role in Next-Generation Vaccine Development, V, vaccine, VacPertagen
(IN BRIEF) AstraZeneca’s Alexion has secured European Commission approval for Koselugo (selumetinib), the first targeted therapy available to adults with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas (PN). The approval is based on the KOMET Phase III trial, … Read the full press release
Posted in Business, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged adult NF1 treatment, Alexion, American Society of Clinical Oncology, APHP, ASCO 2025, AstraZeneca, AstraZeneca Expands Rare Disease Portfolio with EU Approval of Koselugo for Adults with NF1 Tumours, European Commission approval, European Union, Henri Mondor Hospital, Japan approval, KOMET Phase III trial, Koselugo, Marc Dunoyer, MEK inhibitor, neurofibromatosis type 1, NF1, Paris East University, Pierre Wolkenstein, plexiform neurofibromas, PN, rare disease therapy, selumetinib, The Lancet, tumour response rate, UPEC
(IN BRIEF) GSK announced that its B7-H3-targeted antibody-drug conjugate GSK5764227 (GSK’227) has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for the treatment of pulmonary neuroendocrine carcinoma, including small-cell lung cancer (SCLC). The designation is supported … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ADC, antibody-drug conjugate, ARTEMIS-001, B7-H3, breakthrough therapy designation, cancer research, EMA, EMA Grants Orphan Drug Designation to GSK’s B7-H3 Antibody-Drug Conjugate for Pulmonary Neuroendocrine Carcinoma, FDA, GSK, GSK Strengthens Oncology Pipeline With EMA Orphan Drug Status for GSK’227 in Small-Cell Lung Cancer, GSK5764227, GSK’227, immuno-oncology, lung cancer, NEC, ODD, oncology, oncology pipeline, orphan drug designation, PRIME designation, pulmonary neuroendocrine carcinoma, relapsed or refractory, SCLC, Small cell lung cancer, solid tumours, targeted therapy
(IN BRIEF) GSK has signed an exclusive global licensing agreement with Empirico Inc. for EMP-012, a first-in-class siRNA candidate currently in Phase I trials for chronic obstructive pulmonary disease (COPD). EMP-012 targets a distinct inflammatory pathway, offering potential therapeutic benefit … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biologics, Chronic obstructive pulmonary disease, COPD, drug development, EMP-012, Empirico, gene expression, genetic medicine, GSK, GSK Acquires Global Rights to Empirico’s siRNA Candidate EMP-012 for Chronic Obstructive Pulmonary Disease, GSK and Empirico Partner on First-in-Class siRNA Therapy EMP-012 to Address Unmet Needs in COPD, Healthcare Innovation, inflammation, inflammation pathway, Kaivan Khavandi, licensing agreement, oligonucleotide therapeutics, Omri Gottesman, Phase I clinical trial, precision medicine, respiratory diseases, respiratory pipeline, siRNA, type 2 inflammation
(IN BRIEF) Roche announced that its Phase III INShore trial evaluating Gazyva/Gazyvaro (obinutuzumab) in children and young adults with idiopathic nephrotic syndrome met its primary endpoint, showing superior sustained remission rates at one year compared to mycophenolate mofetil (MMF). The … Read the full press release
Posted in Business, Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged B cell targeting, Basel, Chronic kidney disease, corticosteroids, EMA, FDA, Gazyva, Gazyva/Gazyvaro Demonstrates Superior Sustained Remission in Children and Young Adults With Idiopathic Nephrotic Syndrome, Gazyvaro, idiopathic nephrotic syndrome, immune-mediated kidney diseases, INS, INShore study, Levi Garraway, lupus nephritis, NOBILITY study, obinutuzumab, pediatric nephrology, phase III clinical trial, proteinuria, REGENCY study, renal disease, Roche, Roche Announces Positive Phase III INShore Results for Gazyva/Gazyvaro in Children and Young Adults With Idiopathic Nephrotic Syndrome, sustained remission, targeted therapy
(IN BRIEF) Aalborg University (AAU) has appointed Danish Member of Parliament Simon Kollerup, former Minister for Industry, Business and Financial Affairs, as its new external board member. Currently serving as Chair of the Finance Committee and Defence Spokesperson, Kollerup brings … Read the full press release
Posted in Business, Denmark, Education, Financial, Government, Industrial, Investment, Management, News, Science, Society, Technology
Tagged Aalborg University, Aalborg University Strengthens Leadership with Appointment of Simon Kollerup to Its Board, AAU, André Rogaczewski, board appointment, Business Development, Christine Antorini, Danish Parliament, Denmark, Former Minister Simon Kollerup Joins Aalborg University Board to Support Research-Driven Innovation, Governance, higher education, industry collaboration, INNOVATION, leadership, Ministry of Industry Business and Financial Affairs, Public Affairs, RESEARCH, Simon Kollerup, Social Democratic Party, STRATEGY
(IN BRIEF) The Technical University of Munich (TUM), with the support of the Wübben Stiftung Wissenschaft, has established two endowed professorships in Marketing & Technology and AI-Guided Protein Design. Behavioral scientist Dr. David Finken joins TUM from ETH Zurich to … Read the full press release
Posted in Artificial Intelligence (AI), Education, Germany, Management, Science, Technology
Tagged AI-guided protein design, and Digital Transformation Research, artificial intelligence, behavioral science, bioscience, David Finken, digital transformation, endowed professorship, ETH Zurich, Germany, INNOVATION, interdisciplinary research, life sciences, Machine Learning, Marion Müller, marketing and technology, sustainability, Technical University of Munich, Thomas F. Hofmann, Thomas Schlichthärle, TUM, University of Washington, Virtual Reality, Wübben Stiftung Endows Two New TUM Professorships to Advance AI, Wübben Stiftung Wissenschaft
(IN BRIEF) Newcastle University’s Dr Emily Murphy is leading a pioneering project, Sharing Stories for Wellbeing, to explore how creative activities can improve the health and emotional wellbeing of children with long-term medical conditions. With the number of children living … Read the full press release
Posted in Business, Education, Healthcare, Management, News, Science, Society, United Kingdom
Tagged art therapy, child wellbeing, children’s health, clinical psychology, Community Engagement, creative approaches to healthcare, creative health, creative workshops, Dr Emily Murphy, Dr Emily Murphy Leads Newcastle Study on the Role of Creativity in Enhancing Young Patients’ Wellbeing, Great North Museum Hancock, Hatton Gallery, health policy, hospitalised children, long-term conditions, mental health, Newcastle research, Newcastle University, Newcastle University-led Project Sharing Stories for Wellbeing Investigates the Power of Creativity in Enhancing Child Health and Resilience, Paediatric Care, Sharing Stories for Wellbeing, storytelling, wellbeing
(IN BRIEF) University of Leeds graduate Catherine Connolly has been elected as the 10th President of Ireland, following the national vote on 24 October. A 1981 MSc Clinical Psychology alumna, Connolly brings decades of experience as a psychologist, barrister, and … Read the full press release
Posted in Education, Government, Ireland, Management, News, Politics, Science, Technology, United Kingdom
Tagged Áras an Uachtaráin, Catherine Connolly, Dáil Éireann, Galway City Council, Galway West, higher education, independent candidate, Ireland, Irish election, Irish government, Irish politics, Labour Party, leadership, Leas Cheann Comhairle, Leeds alumni, Political leadership, President of Ireland, Public Service, Shearer West, UK Prime Minister, University of Leeds, University of Leeds Celebrates Alumna Catherine Connolly’s Election as President of Ireland, women in politics
(IN BRIEF) Evotec SE announced it has received a US$ 25 million payment from Bristol Myers Squibb, marking progress in their joint neuroscience partnership focused on neurodegenerative diseases. The milestone payment will further advance the companies’ preclinical pipeline and research … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science, Technology
Tagged biotechnology, BMS-986419, Bristol-Myers Squibb, clinical trials, Cord Dohrmann, disease-modifying therapies, drug discovery, Evotec and Bristol Myers Squibb Advance Neuroscience Collaboration with New Funding Milestone, Evotec SE, EVT8683, milestone payment, neurodegenerative diseases, neuroscience, neuroscience collaboration, neuroscience research, pharmaceutical innovation, preclinical research, strategic partnership, translational medicine
(IN BRIEF) The Det Norske Veritas Foundation has launched a NOK 2 billion (USD 200 million) research fund aimed at supporting basic scientific research in the Nordic region. Expected to provide NOK 50–100 million annually, the fund will finance projects … Read the full press release
Posted in Business, Energy, Gas & Oil, Industrial, Investment, News, Norway, Science, Society, Technology
Tagged autonomy, Det Norske Veritas Foundation, digital systems, DNV, DNV Foundation Launches Major Research Fund to Drive Scientific and Societal Development Across the Nordic Region, DNV research and development, Environment, higher education, industry, INNOVATION, Jon Fredrik Baksaas, knowledge development, new critical raw materials, New NOK 2 Billion Fund Strengthens Det Norske Veritas Foundation’s Commitment to Nordic Research and Sustainability, Nordic Region, Norway, Remi Eriksen, research fund, safety, scientific research, Sigrun Aasland, societal risks, sustainability, value creation
(IN BRIEF) Schneider Electric and Roca Group have partnered to advance a global digital transformation that enhances operational efficiency, energy performance, and sustainability across Roca’s industrial network. Through technologies like AVEVA MES, AVEVA System Platform, and Power Monitoring Expert, Roca’s … Read the full press release
Posted in Denmark, Energy, Gas & Oil, Environment, Industrial, Management, Science, Technology
Tagged AVEVA MES, AVEVA PI System, AVEVA System Platform, Carlos Velázquez, decarbonization, digital transformation, EcoVadis Platinum Medal, energy efficiency, Friedrich Richter, industrial automation, Jacques Nieuwland, Le Vaudreuil Lighthouse Factory, Miquel Barahona, Operational Efficiency, Power Monitoring Expert, renewable energy, Roca Group, Schneider Electric, Schneider Electric partnership helps Roca achieve efficiency gains and sustainability milestones through digital innovation, smart factories, sustainability
(IN BRIEF) Schneider Electric has introduced Schneider Boost Pro, a scalable battery energy storage system designed for European commercial and industrial users to manage energy more efficiently, lower costs, and maintain operational continuity. The system supports renewable energy integration, electric … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, Energy, Gas & Oil, Industrial, Infrastructure & Utilities, Science, Technology
Tagged AI-driven insights, Anthony Song, battery energy storage, commercial buildings, Cybersecurity, EcoStruxure Microgrid Advisor, Energy management, energy transition, EV charging infrastructure, grid stability, industrial energy solutions, renewable energy, Schneider Boost Pro, Schneider Electric, Schneider Electric expands energy resilience in Europe with scalable Schneider Boost Pro battery storage system, sustainability
(IN BRIEF) Three researchers from Eindhoven University of Technology — Ahmed Dorrah, Jaime Bonnin Roca, and Hamdi Joudeh — have each received NWO Vidi grants worth up to €850,000 to advance their individual research programs. The funding enables them to … Read the full press release
Posted in Awards, Education, Financial, Government, Industrial, Investment, Netherlands, News, Science, Security & Safety, Technology
Tagged Ahmed Dorrah, Autonomous Vehicles, Brainport Region, Eindhoven University of Technology, Eindhoven University of Technology Strengthens Research Excellence with Three NWO Vidi Grant Recipients, energy efficiency, government innovation, Hamdi Joudeh, information theory, innovation policy, Jaime Bonnin Roca, nano-optics, Netherlands science, NWO, photonics, Quantum technology, research funding, semiconductor, TU/e, Vidi grants, wireless sensing
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?